Literature DB >> 3426921

Redistribution of blood flow in experimental hepatic tumours with noradrenaline and propranolol.

M A Burton1, B N Gray.   

Abstract

Noradrenaline induced changes in the distribution of blood flow in implanted tumour and normal liver tissue was measured using blood flow tracer microspheres. The ratio of embolised microspheres in tumour compared to normal tissue was determined before and after the intravenous infusion of noradrenaline, propranolol and a combination of the two drugs. The ratio was significantly decreased by noradrenaline alone but significantly increased when propranolol was added to the infusate. Propranolol had no effect on the ratio. The drug combination increased the tumour to normal ratio by approximately 69% and also doubled the proportion of microspheres entering the internal tumour circulation. This represents an enhanced relative blood supply to tumour and would provide a means of preferential carriage of blood borne cytotoxic agents to tumour tissue rather than normal tissue.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426921      PMCID: PMC2001891          DOI: 10.1038/bjc.1987.245

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

2.  Experimental studies on the circulation dynamics of intrahepatic tumor blood supply.

Authors:  N B Ackerman
Journal:  Cancer       Date:  1972-02       Impact factor: 6.860

3.  Adrenergic responses of the hepatic circulation.

Authors:  G Ross; M Kurrasch
Journal:  Am J Physiol       Date:  1969-06

4.  Microcirculatory mechanisms in experimental tumors.

Authors:  N V Krylova
Journal:  Bibl Anat       Date:  1977

5.  An evaluation of the response of the microvasculature in tumors in C3H mice to vasoactive drugs.

Authors:  J K Wickersham; W P Barrett; S B Furukawa; H W Puffer; N E Warner
Journal:  Bibl Anat       Date:  1977

6.  Effects of pharmacological agents on the microcirculation of tumors implanted in the liver.

Authors:  N B Ackerman; P A Hechmer
Journal:  Bibl Anat       Date:  1977

7.  Effect of vasoactive drugs on tissue blood flow in the hamster melanoma.

Authors:  R F Edlich; W Rogers; C V DeShazo; J B Aust
Journal:  Cancer Res       Date:  1966-07       Impact factor: 12.701

8.  The effects of stimulation of the hepatic nerves, infusions of noradrenaline and occlusion of the carotid arteries on liver blood flow in the anaesthetized cat.

Authors:  C V Greenway; A E Lawson; S Mellander
Journal:  J Physiol       Date:  1967-09       Impact factor: 5.182

9.  Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II.

Authors:  M A Burton; B N Gray; G W Self; J C Heggie; P S Townsend
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

10.  The effects of intraportal injections of noradrenaline, adrenaline, vasopressin and angiotensin on the hepatic portal vascular bed of the dog: marked tachyphylaxis to angiotensin.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-02       Impact factor: 8.739

View more
  5 in total

1.  Thrombospondin 1 and vasoactive agents indirectly alter tumor blood flow.

Authors:  Jeff S Isenberg; Fuminori Hyodo; Lisa A Ridnour; Caitlin S Shannon; David A Wink; Murali C Krishna; David D Roberts
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

2.  An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.

Authors:  M V Pimm
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

3.  The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour.

Authors:  D M Hemingway; T G Cooke; D Chang; S J Grime; S A Jenkins
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

4.  Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Vidula Sukhatme; Lydie Meheus; Ilse Rooman; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2016-10-12

5.  Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma.

Authors:  Emmanuel M Gabriel; Minhyung Kim; Daniel T Fisher; Colin Powers; Kristopher Attwood; Sanjay P Bagaria; Keith L Knutson; Joseph J Skitzki
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.